Christos Argyropoulos MD, PhD, FASN 🇺🇸 0kale/accIf a physician practice could get somehow get their Medicare patients on #angiotensin blockade #flozin #nsMRA and #glp1 (e.g. secondary insurance or coinsurance) why would they partner with a #VBC and share cost savings from the drugs? Just write a script & use the ...
Viet Le, MPAS PA-C FACC FAHAThanks to all who attended. Follow the link to revisit our #cardiology #bootcamp
#PhysicianAssociate #NursePractitioner #sglt2i #nsMRA #resistantHTN @APAC_Cardiology @brianrosePAS @Lross246 @leyadiel @GiaconaJohn https://www.instagram.com/p/CmwmurbLYUM/?igshid=MDJmNzVkMjY=
#PhysicianAssociate #NursePractitioner #sglt2i #nsMRA #resistantHTN @APAC_Cardiology @brianrosePAS @Lross246 @leyadiel @GiaconaJohn https://www.instagram.com/p/CmwmurbLYUM/?igshid=MDJmNzVkMjY=
Academy of PAs in Cardiology on Instagram: "Over 300 learners tuned in for the Cardiology boot camp livestream CME collaboration with PCE and APAC on 12/11/22. Bootcamp takeaways included: SGLT2 inhibitors should be considered for anyone with HFpEF, HFrEF, diabetes and kidney disease - and as one of the four pillars for CHF. This was something the specialists in cardiology, endocrinology and nephrology all agreed on! Think about Finerenone for patients with chronic kidney disease and diabetes to prevent worsening renal function and cardiovascular protection. Lastly, there are many options for treating resistant hypertension - rule out compliance issues/barriers to care first, but next think about hyperaldosteronism. Visit the link in bio to register and view the slide decks and more in-depth coverage of those topics. #PCE #cardiologybootcamp #PAevent #PAs #APAC #academyofpasincardiology #heartPA #ANCC #AAPA #PAs #NPs #CV #cardiovasculardisease"
Academy of PAs in Cardiology shared a post on Instagram: "Over 300 learners tuned in for the Cardiology boot camp livestream CME collaboration with PCE and APAC on 12/11/22. Bootcamp takeaways included: SGLT2 inhibitors should be considered for anyone with HFpEF, HFrEF, diabetes and kidney disease - and as one of the four pillars for CHF. This was something the specialists in cardiology, endocrinology and nephrology all agreed on! Think about Finerenone for patients with chronic kidney disease and diabetes to prevent worsening renal function and cardiovascular protection. Lastly, there are many options for treating resistant hypertension - rule out compliance issues/barriers to care first, but next think about hyperaldosteronism. Visit the link in bio to register and view the slide decks and more in-depth coverage of those topics. #PCE #cardiologybootcamp #PAevent #PAs #APAC #academyofpasincardiology #heartPA #ANCC #AAPA #PAs #NPs #CV #cardiovasculardisease". Follow their account to see 460 posts.
LittleBigGloms@hswapnil @mike_johansen This is cool! We are working on medication specific guidelines to harmonize prescriptions of #Flozins, #GLP1ra, #nsMRA etc across #primarycare, #cardiology, #endocrinology and #nephrology, which has been a fun project. I think at our institution, nephrology prescribed most aggressively, but that is probably the effect of having Amy Mottl in our division.